Advances in Ontology--Based Mining of Adverse Drug Reactions
Kenenisa Tadesse Dame, Pietro Belloni, Ugo Moretti, Fabio Scapini, Marco Tuccori, Alessandra R. Brazzale

TL;DR
This paper introduces an ontology-based statistical model for improved detection of adverse drug reactions in pharmacovigilance, effectively accounting for AE similarities and zero-inflation, and proposes a data splitting method for reliable evaluation.
Contribution
It presents a novel integration of AE ontology into a zero-inflated negative binomial model and introduces a data thinning technique for better model validation in pharmacovigilance.
Findings
Ontology-based model outperforms classical models like GPS.
Data thinning and stratified splitting improve evaluation reliability.
Method effectively accounts for AE similarities and zero counts.
Abstract
Post--marketing pharmacovigilance is essential for identifying adverse drug reactions (ADRs) that elude detection during pre--marketing clinical trials. This study explores a novel approach that integrates an adverse event (AE) ontology into a zero--inflated negative binomial model to improve ADR detection. By accounting for the biological similarities among correlated AEs and addressing the excess of zero counts, this method more effectively disentangles AE associations. Statistical significance is evaluated using a permutation--based maximum statistic that preserves AE correlations within individual reports. Simulations and an application to real data from the Veneto drug safety database demonstrate that the ontology--based model consistently outperforms classical models such as the Gamma--Poisson Shrinker (GPS). For post--selection inference, we furthermore explore a data thinning…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Computational Drug Discovery Methods · Biomedical Text Mining and Ontologies
